Edit |   |
---|---|
Antigenic Specificity | ITGA4 & ITGB7, Human (Etrolizumab biosimilar) |
Clone | Etrolizumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | IF, IP, Neut, FuncS, ELISA, FCM |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human ITGA4 & ITGB7 Recombinant Antibody (Etrolizumab). Etrolizumab (rhuMAb Beta7) is a biopharmaceutical drug candidate being developed for the treatment of ulcerative colitis and Crohn's disease. It is a humanized monoclonal antibody against the 7 subunit of integrins 4 7 and E 7. |
Immunogen | n/a |
Other Names | Anti-ITGA4 & ITGB7 Recombinant Antibody, Research Grade Etrolizumab, Anti-Human ITGA4 & ITGB7 Recombinant Antibody(Etrolizumab), Anti-Beta7, PRO145223, RG7413, Antibody Drug Analogues, Monoclonal Antibody, YR1242, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1044758-60-2 |
Catalog # | YR1242 |
Price | please inquire |
Order / More Info | ITGA4 & ITGB7, Human (Etrolizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |